Investing.com - J&J reported on Tuesday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
J&J announced earnings per share of $2.13 on revenue of $24.8B. Analysts polled by Investing.com EPS of $2.12 on revenue of $25.28B.
J&J 's are down 4% and is trading at $162.97 , still down 9.42% from its 52 week high of $179.92 set on Friday, August 20, 2021.
J&J follows other major Healthcare sector earnings this month
J&J's report follows an earnings beat by UnitedHealth on Wednesday, January 19, 2022, who reported EPS of $4.48 on revenue of $73.74B, EPS of $4.3 on revenue of $72.98B.
Intuitive Surgical had beat expectations on Thursday with fourth quarter EPS of $1.3 on revenue of $1.55B, for EPS of $1.28 on revenue of $1.52B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar